Article

Ddailyvoiceplus.com on 2019-04-25 14:44

FDA grants generic therapy designation for Purdue Pharma’s opioid overdose treatment

The U.S. Food & Drug Administration’s Office of Generic Drugs has granted Purdue Pharma LP a competitive generic therapy designation for its ...

Related news

After pushing addictive OxyContin, Purdue now pursuing overdose antidote Ars Technica
Massachusetts , United States
Congress Excoriates Sacklers Over Purdue Pharma’s Role In Opioid Crisis Forbes
Minnesota , New York , Americas
Sacklers, States Duel Over Purdue Pharma’s Prebankruptcy Payouts wsj.com
Institutions Rethink Donations From Purdue Pharma’s Sackler Family wsj.com
Americas
The Met Stops Taking Gifts From Purdue Pharma’s Sacklers wsj.com
New York
Purdue Pharma’s foreign affiliate now selling overdose cure Denver Post
Manchester , United Kingdom , Sweden , Norway , New South Wales
Mundipharma, Purdue Pharma’s Foreign Affiliate, Now Selling Opioid Overdose Cure KTLA 5
MCelcuity stock soars after hours on breakthrough therapy designation for cancer drug1 min read marketwatch.com
Fast Track
FDA Talks Regenerative Medicine Advanced Therapy Designation jdsupra.com
United States
DJulie Ducharme named chief scientific officer at Purdue Pharma dailyvoiceplus.com
Fairfield , West Chester
Nan Goldin Testifies at Landmark Hearing On Purdue Pharma’s Role In Opioid Crisis hyperallergic.com
FDA OKs 1st generic nasal spray of overdose reversal drug abqjournal.com
Israel
FDA Prioritizes Review Generic Drug Products to Treat Opioid Overdose jdsupra.com
California , United States , Switzerland
Purdue Pharma’s Sacklers to Get Back More Than $90 Million From Fund wsj.com
Judge Throws Out Purdue Pharma’s Deal to Shield Sacklers From Opioid Lawsuits wsj.com
MBeiGene drug gets 'breakthrough therapy' designation from FDA marketwatch.com